Phibro Animal Health CorporationPAHCNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +23.73% | +32.14% | +38.63% | +39.73% | +20.90% |
| Gross Profit Growth | +29.58% | +31.37% | +26.23% | +43.46% | +30.22% |
| EBITDA Growth | +43.00% | +86.83% | +109.47% | +133.53% | +163.16% |
| Operating Income Growth | +62.62% | +68.21% | +83.09% | +170.59% | +113.11% |
| Net Income Growth | +150.00% | +148.42% | +2190.43% | +280.32% | +762.14% |
| EPS Growth | +166.67% | +147.62% | +2158.06% | +282.35% | +750.00% |
| EPS Diluted Growth | +166.67% | +142.86% | +2158.06% | +282.35% | +737.50% |
| Weighted Average Shares Growth | +0.00% | -0.01% | -0.01% | +0.07% | +0.07% |
| Weighted Average Shares Diluted Growth | +0.52% | +0.47% | +0.44% | +0.73% | +0.59% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -90.25% | +278.28% | -25.17% | -26.30% | +529.13% |
| Free Cash Flow Growth | -123.04% | +2011.39% | -47.06% | -248.21% | +0.00% |
| Receivables Growth | +27.33% | +22.62% | +34.54% | +35.53% | +12.56% |
| Inventory Growth | +49.02% | +58.84% | +67.13% | +73.09% | +21.10% |
| Asset Growth | +32.16% | +34.55% | +38.56% | +43.39% | +9.34% |
| Book Value per Share Growth | -8.86% | -1.51% | +11.33% | +20.47% | +34.57% |
| Debt Growth | +53.86% | +47.23% | +44.93% | +53.37% | -2.06% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +21.33% | +19.06% | +10.99% | +8.60% | +2.05% |